Tertiary cytoreduction in patients with recurrent ovarian carcinoma

Gynecologic Oncology
M M LeitaoDennis S Chi

Abstract

The literature on the role of cytoreductive surgery beyond the secondary cytoreductive setting is limited. In this study, we reviewed the outcomes of patients with recurrent epithelial ovarian carcinoma who underwent tertiary cytoreduction. We performed a retrospective chart review of all patients with recurrent epithelial ovarian carcinoma who underwent tertiary cytoreduction at our institution from 1/1/90 to 12/31/02. Disease-specific survival (DSS) was calculated from the time of tertiary cytoreduction to last follow-up. Univariate and multivariate analyses were used to analyze outcomes and to identify potential prognostic factors. A total of 26 patients were identified. The median follow-up after tertiary cytoreduction was 22.3 months (range, 0-71.7 months), with an overall median DSS of 33.4 months (95%CI, 20.4-46.4). On univariate analysis, treatment-free interval (TFI) before tertiary cytoreduction and residual disease after the procedure, as well as time to first recurrence, were found to be significant prognostic factors. Median DSS was 15 months for a TFI < or =12 months compared with 60.4 months for a TFI > 12 months (P = 0.002). The median DSS for patients with residual disease < or =0.5 cm was 36.3 months compared ...Continue Reading

References

Mar 10, 2001·American Journal of Clinical Oncology·J GiblinW P McGuire
Aug 25, 2001·Gynecologic Oncology·D S ChiW J Hoskins
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert E BristowF J Montz
May 30, 2002·Annals of Surgery·Robert C G MartinDavid P Jaques
Jun 8, 2002·Obstetrics and Gynecology·Eng Hseon TayNeville F Hacker
Jun 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·George A OmuraSusan G Arbuck
Oct 8, 2003·Gynecologic Oncology·Mario M LeitaoDavid R Spriggs
May 1, 1996·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A AyhanA Ayhan

❮ Previous
Next ❯

Citations

Jan 1, 2006·Women's Health·Gamal H Eltabbakh, Scott Goodrich
Mar 15, 2013·JSLS : Journal of the Society of Laparoendoscopic Surgeons·Farr R NezhatPrakash Saharia
Sep 30, 2006·Annals of Surgical Oncology·Philipp HarterUNKNOWN AGO Ovarian Cancer Study Group
Aug 11, 2010·Annals of Surgical Oncology·Christina FotopoulouJalid Sehouli
Oct 12, 2012·Annals of Surgical Oncology·Christina FotopoulouJalid Sehouli
Mar 16, 2013·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·J TangR Y Zang
Apr 7, 2012·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Deniz HızlıM Faruk Köse
Sep 29, 2011·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·J M ClasseL Campion
Oct 22, 2008·Gynecologic Oncology·Robert E BristowDennis S Chi
Oct 22, 2008·Journal of Surgical Oncology·Murat GultekinAli Ayhan
Apr 1, 2009·Seminars in Oncology·Mario M Leitao, Dennis S Chi
Feb 24, 2006·Gynecologic Oncology·Christopher S AwtreyDennis S Chi
Jul 16, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Elena-Ioana BraicuChristina Fotopoulou
May 1, 2016·Gynecologic Oncology·Dong Hoon SuhRobert E Bristow
Jan 29, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Philipp HarterAndreas du Bois
Jan 16, 2007·Current Opinion in Obstetrics & Gynecology·Jan Hauspy, Allan Covens
Jul 30, 2009·Annals of Surgery·Steven M StrasbergWilliam G Hawkins
Jul 9, 2010·Journal of Gynecologic Oncology·Karin K Shih, Dennis S Chi
Aug 12, 2005·Current Opinion in Oncology·Philipp Harter, Andreas du Bois
Jan 17, 2013·British Journal of Cancer·C FotopoulouJ Sehouli
Feb 22, 2012·Clinical Obstetrics and Gynecology·Ritu Salani, Robert E Bristow
Oct 19, 2013·Oncology Letters·Nasuh Utku DoganPolat Dursun
Jan 23, 2020·Cancer·Jalid Sehouli, Jacek P Grabowski
May 26, 2016·Asian Pacific Journal of Cancer Prevention : APJCP·Macit ArvasMutlu Meydanli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.